Rebecca A Atherton

Title: The Innovations of Rebecca A. Atherton

Introduction

Rebecca A. Atherton is a notable inventor based in Shawnee, Kansas. She has made significant contributions to the field of veterinary medicine, particularly in the development of feline vaccines. Her work has had a positive impact on the prevention and treatment of chlamydia diseases in cats.

Latest Patents

Rebecca holds a patent for her invention titled "Feline vaccines containing Chlamydia psittaci and method for making the." This invention relates to feline vaccines that comprise inactivated non-reactive Chlamydia psittaci, aimed at preventing and treating chlamydia diseases in cats. This innovative approach has the potential to improve the health and well-being of feline companions.

Career Highlights

Throughout her career, Rebecca has worked with prominent companies in the pharmaceutical and veterinary sectors. Notably, she has been associated with Bayer Corporation and Baker Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in vaccine development and veterinary medicine.

Collaborations

Rebecca has collaborated with esteemed colleagues in her field, including Norbert Schmeer and Jean A. Hallstrom. These partnerships have fostered innovation and advancement in the development of veterinary vaccines.

Conclusion

Rebecca A. Atherton's contributions to veterinary medicine through her innovative vaccine development exemplify her dedication to improving animal health. Her work continues to influence the field positively, ensuring better care for feline patients.